Professor Yosef Yarden

August 9, 2023

A Select Group: Study May Bring Improved Therapy to Preselected Lung Cancer Patients

Researchers at the Weizmann Institute of Science have identified a biomarker that may one day enable a subgroup of lung cancer patients to benefit from relapse-free treatment. Non-smokers who develop...

eastRead More